We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The U.S. Court of Appeals for the Federal Circuit has reportedly refused to revisit an earlier ruling in which it reinstated a patent infringement case brought by Schering AG affiliate Medrad against Tyco Healthcare and three co-defending firms.
EvYsio Medical Devices has won an injunction against affiliates of Abbott Laboratories barring the importation, offering for sale or sale of Abbott's Xience V drug-eluting stent in France, evYsio announced.
Dupaco violated current good manufacturing practices by not performing required tests or following complaint procedures with its blood/fluid warming sets, according to an FDA warning letter.
Nearly one-third of patients suffering from ischemic cardiomyopathy, or congestive heart failure (CHF), may not benefit from implantable cardioverter defibrillators (ICDs).
Innogenetics, a biopharmaceutical firm building a parallel business in specialty diagnostics, announced that a U.S. District Court judge for the Western District of Wisconsin affirmed a previously awarded $7 million damage verdict against Abbott Laboratories for infringing Innogenetics' hepatitis C virus (HCV) genotyping patent.
Healthcare providers have to consider what the Centers for Medicare & Medicaid Services (CMS) will reimburse them for when deciding to purchase new medical devices.
Device clinical trial sponsors will be subject to new requirements under FDA draft guidance on the format, content and review of reports related to clinical postapproval studies.
Solexa, a firm that develops genetic research technologies, said Dec. 29 it had become aware of a lawsuit filed against it by Applera's Applied Biosystems Group in a California state court Dec. 26.